Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00315
|
|||||
Drug Name |
Alitretinoin
|
|||||
Synonyms |
(9cis)-retinoic acid; 5300/3/8; 9(Z)-Retinoic acid; 9-CIS-RETINOIC ACID; 9-cis Retinoic Acid; 9-cis-Tretinoin; ALRT-1057; Alitretinoin; Alitretinoin (USAN); Alitretinoin [USAN]; Panretin; Panretin (TN); Panretin Gel; Panretyn; Panrexin; Retinoic acid, 9-cis-; Toctino; alitretinoina; alitretinoine; alitretinoinum
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Anticancer Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C20H28O2
|
|||||
Canonical SMILES |
CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C
|
|||||
InChI |
InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+
|
|||||
InChIKey |
SHGAZHPCJJPHSC-ZVCIMWCZSA-N
|
|||||
CAS Number |
CAS 5300-03-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 300.4 | Topological Polar Surface Area | 37.3 | ||
Heavy Atom Count | 22 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | |||
XLogP |
6.3
|
|||||
PubChem CID | ||||||
PubChem SID |
10300319
, 11528315
, 12014910
, 14898408
, 17396485
, 17396973
, 17486479
, 22391507
, 24702085
, 24899373
, 25622044
, 25641192
, 26681478
, 26718599
, 26755227
, 26755228
, 26755229
, 26755230
, 36890827
, 3718107
, 46507356
, 47811003
, 47885624
, 47885625
, 50087219
, 50110876
, 50110877
, 50110878
, 509159
, 53790163
, 53801213
, 56310968
, 56313931
, 56313962
, 57288659
, 57404908
, 57571034
, 584816
, 75174291
, 7978614
, 8026464
, 838980
, 85240518
, 85279329
, 85788016
, 87219231
, 90451653
, 92309911
, 99300825
, 99302343
|
|||||
ChEBI ID |
ChEBI:50648
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.